Leverages over 40 years of entrepreneurial experience across multiple sectors, we strategically invest in life sciences. With a focus on medical therapies that address unmet needs, M&L Healthcare seeks to be a leader in the development of transformative and sustainable healthcare solutions. Our commitment is grounded in sound clinical evidence and a mission to build a legacy that transcends financial return.

Wholly owned by Grandline International Pte. Ltd, and part of the M&L Group, M&L Healthcare embodies the Kum family’s philosophy of combining business expertise with a long-term vision to create meaningful impact. We target innovative healthcare applications that improve lives, aspiring to set new standards in medical technology and ethical investment.